Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Medicine and Dentistry

• Chemoradiation Therapy 100%
• Radioembolization 45%
• Therapeutic Procedure 20%
• Patient 16%
• Hepatocellular Carcinoma 12%
• Complication 8%
• Overall Survival 8%
• Liver Cancer 8%
• Combination Therapy 4%
• Tumor Progression 4%
• Surgery 4%
• Survival Rate 4%
• Malignant Neoplasm 4%
• Liver Transplantation 4%
• Radiation Therapy 4%
• Cancer Staging 4%
• Fluorouracil 4%
• Propensity Score Matching 4%
• Cancer Classification 4%
• Yttrium 90 4%
• Age 4%
• Portal Vein Thrombosis 4%
• Hepatic Arterial Infusion 4%
• Analysis 4%

Nursing and Health Professions

• Radioembolization 45%
• Inpatient 16%
• Group Therapy 12%
• Complication 8%
• Overall Survival 8%
• Liver Cancer 8%
• Hospital 8%
• Survival Rate 4%
• Surgery 4%
• Propensity Score 4%
• Combination Therapy 4%
• Tumor Volume 4%
• Cancer Staging 4%
• Malignant Neoplasm 4%
• Chemotherapy 4%
• Procedures 4%
• Analysis 4%
• Device Material 4%
• Fluorouracil 4%
• Tumor Number 4%
• Liver Transplantation 4%
• Tumor Growth 4%
• Cancer Classification 4%
• Yttrium 90 4%
• Portal Vein Thrombosis 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Cell Carcinoma 12%
• Complication 8%
• Overall Survival 8%
• Liver Cancer 8%
• Tumor Growth 4%
• Fluorouracil 4%
• Survival Rate 4%
• Malignant Neoplasm 4%
• Cancer Staging 4%
• Portal Vein Thrombosis 4%
• Yttrium 90 4%
• Cancer Classification 4%